GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Itoco Inc (OTCPK:ITMC) » Definitions » Total Long-Term Assets

Itoco (ITMC) Total Long-Term Assets : $1.14 Mil (As of Sep. 2010)


View and export this data going back to 2009. Start your Free Trial

What is Itoco Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Itoco's Total Long-Term Assets for the quarter that ended in Sep. 2010 was $1.14 Mil.


Itoco Total Long-Term Assets Historical Data

The historical data trend for Itoco's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itoco Total Long-Term Assets Chart

Itoco Annual Data
Trend Dec08 Dec09
Total Long-Term Assets
3.94 3.13

Itoco Quarterly Data
Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 3.13 3.15 1.17 1.14

Itoco Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


Itoco Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Itoco's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Itoco (ITMC) Business Description

Traded in Other Exchanges
N/A
Address
50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Itoco Inc is focused on developing and bringing biotech products to the market via co-development and joint venture arrangements with various companies. The company is currently examining various technologies that seek to control and/or identify bio-contaminants such as viruses and bacteria.